JMP Securities Reiterates Market Outperform on Aura Biosciences, Maintains $19 Price Target
Portfolio Pulse from Benzinga Newsdesk
JMP Securities has reiterated its Market Outperform rating for Aura Biosciences, maintaining a price target of $19.
August 28, 2024 | 2:33 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
JMP Securities has reiterated its Market Outperform rating for Aura Biosciences, maintaining a price target of $19. This suggests confidence in the company's future performance.
The reiteration of a Market Outperform rating and a maintained price target of $19 by JMP Securities indicates a positive outlook on Aura Biosciences' stock. This could lead to increased investor confidence and potentially a positive short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100